Randomized clinical trial “Olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. treatment with Palmitoylethanolamide and Luteolin” – preliminary results
The article “Randomized clinical trial ‘olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin’: preliminary results”, published in the European Review for Medical and Pharmacological Sciences by Prof. Di Stadio et al., focuses on persistent smell and taste disorders as long-term sequelae of COVID-19 infection.
The study evaluates a three-phase therapeutic approach and shows that treated patients regained olfactory function after approximately two months. Prof. Di Stadio further explains the findings in an interview with Il Fatto Quotidiano (full interview here:
click here).